EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

4‐octyl itaconate alleviates cisplatin‐induced ferroptosis possibly via activating the NRF2 / HO ‐1 signalling pathway

Li Zhang, Wenao Song, Hua Li, Xiaolin Cui, Jingyu Ma, Rongrong Wang, Yue Xu, Ming Li, Xiaohui Bai iD, Dawei Wang iD, Haihui Sun, Zhiming Lu iD

Journal of Cellular and Molecular Medicine · 2024

DOI: 10.1111/jcmm.18207 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2024. Verfasst von Li Zhang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China. Hauptthemen laut MEDLINE: Ferroptosis, Hearing Loss, Succinates. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Key Research and Development Project of Shandong Provence, China, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ferroptosis, characterized by iron‐dependent lipid reactive oxygen species (ROS) accumulation, plays a pivotal role in cisplatin‐induced ototoxicity. Existing research has suggested that in cisplatin‐mediated damage to auditory cells and hearing loss, ferroptosis is partially implicated. 4‐Octyl itaconate (4‐OI), derived from itaconic acid, effectively permeates cell membranes, showcasing potent anti‐inflammatory as well as antioxidant effects in several disease models. Our study aimed to investigate the effect of 4‐OI on cisplatin‐induced ferroptosis and the underlying molecular mechanisms. The survival rates of HEI‐OC1 cells and mice cochlea hair cells were measured by CCK8 and immunofluorescence, respectively. The auditory brainstem response (ABR) audiometry was used to detect changes in hearing thresholds in mice before and after treatment. Levels of ROS were evaluated by DCFH‐DA. Real‐time PCR quantified inflammatory cytokines TNF‐α, IL‐6 and IL‐1β. Network Pharmacology and RNA sequencing (RNA‐seq) analysis of the potential mechanism of 4‐OI resistance to cisplatin‐induced ferroptosis. The expressions of ferroptosis‐related factors (GPX4, SLC7A11 and PTGS2) and important antioxidant factors (NRF2, HO‐1, GCLC and NQO1) were tested by real‐time PCR, Western blot and immunofluorescence. Results demonstrated cisplatin‐induced significant ROS and inflammatory factor release, reduced NRF2 expression, hindered nuclear translocation and activated ferroptosis. Pretreatment with 4‐OI exhibited anti‐inflammatory and antioxidant effects, along with resistance to ferroptosis, ultimately mitigating cisplatin‐induced cell loss. In the present study, we show that 4‐OI inhibits cisplatin‐induced ferroptosis possibly through activation of the NRF2/HO‐1 signalling pathway, thereby exerting a protective effect against cisplatin‐induced damage to auditory cells, and providing a new therapeutic strategy for cisplatin‐induced hearing loss.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisHearing LossSuccinatesAnimalsMiceCisplatinNF-E2-Related Factor 2Reactive Oxygen SpeciesAntioxidantsApoptosisAnti-Inflammatory Agents

Stichwörter der Autor:innen

4-octyl itaconateNRF2cisplatinferroptosisototoxicity

Substanzen

Cisplatin4-octyl itaconateNF-E2-Related Factor 2Reactive Oxygen SpeciesAntioxidantsAnti-Inflammatory AgentsSuccinates

Autor:innen und Institutionen

  • Department of Laboratory Medicine, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.
  • Department of Laboratory Medicine, Shandong Provincial Hospital, Shandong University, Jinan, Shandong, China.
  • Department of Laboratory Medicine, Weishan County Second People's Hospital, Jining, Shandong, China.
  • Center for Reproductive Medicine, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China.
  • Department of Orthopaedics, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.
  • Department of Cardiology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.

ORCID-Profile: Xiaohui Bai, Dawei Wang, Zhiming Lu

Förderung

  • Key Research and Development Project of Shandong Provence, China
  • National Natural Science Foundation of China

Zitieren

APA

Zhang, L., Song, W., Li, H., Cui, X., Ma, J., Wang, R., Xu, Y., Li, M., Bai, X., Wang, D., Sun, H., & Lu, Z. (2024). 4‐octyl itaconate alleviates cisplatin‐induced ferroptosis possibly via activating the NRF2 / HO ‐1 signalling pathway. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.18207

Vancouver

Zhang L, Song W, Li H, Cui X, Ma J, Wang R, et al. 4‐octyl itaconate alleviates cisplatin‐induced ferroptosis possibly via activating the NRF2 / HO ‐1 signalling pathway. Journal of Cellular and Molecular Medicine. 2024. doi:10.1111/jcmm.18207

BibTeX
@article{Zhang2024,
  author = {Zhang, Li and Song, Wenao and Li, Hua and Cui, Xiaolin and Ma, Jingyu and Wang, Rongrong and Xu, Yue and Li, Ming and Bai, Xiaohui and Wang, Dawei and Sun, Haihui and Lu, Zhiming},
  title = {4‐octyl itaconate alleviates cisplatin‐induced ferroptosis possibly via activating the NRF2 / HO ‐1 signalling pathway},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2024},
  doi = {10.1111/jcmm.18207}
}
Kostenlos starten →